Characterization of CTLA-4 structure and expression on human T cells

Area of Science:

• Immunology
• Cell Biology

Background:

• Cytotoxic T-Lymphocyte-Associated protein 4 (CTLA-4) is an adhesion receptor on activated T cells, related to CD28.
• Both CTLA-4 and CD28 share the B7 counter-receptor on antigen-presenting cells, but CTLA-4's function is unknown.
• CTLA-4 is coexpressed with CD28 on activated T cells, but only CD28 is found on resting T cells.

Purpose of the Study:

• To investigate the expression patterns and protein characteristics of CTLA-4 on T cells.
• To understand the relationship between CTLA-4 and CD28 expression and activation.
• To explore the potential distinct roles of CTLA-4 and CD28 in T cell signaling.

Main Methods:

• Analysis of CTLA-4 and CD28 mRNA expression in T cells under various activation conditions (phorbol ester, calcium ionophore, CD28 ligation).
• Generation of rabbit antiserum against CTLA-4 for protein detection.
• Radiolabeling of T cells ([35S]methionine, 125I) and immunoprecipitation/SDS-PAGE to analyze CTLA-4 protein size and complex formation.

Main Results:

• CTLA-4 expression is restricted to T cells that also express CD28.
• CTLA-4 mRNA induction is mediated by protein kinase C activation, enhanced by calcium signaling, and also induced by CD28 ligation.
• CTLA-4 protein is detected as a 41- to 43-kDa monomer on the cell surface, not as a disulfide-bonded dimer with itself or CD28.

Conclusions:

• CTLA-4 and CD28 represent distinct receptor complexes for B7 binding on T cells, potentially mediating different biological functions.
• Noncovalent interactions may be involved in the cell surface association of CTLA-4 and CD28.
• Further research is needed to elucidate the specific functional roles of CTLA-4 and CD28 signaling pathways.